Page 948 - Textbook of Pathology, 6th Edition
P. 948

932 Tophi, 854f                           meninges, 876                      stress, 550
           TORCH complex, 190-91                miliary, 162                     Ulcerative colitis, versus Crohn’s disease, 566t
           Torsion testis, 706                  nose, 517                        Ultimate carcinogens, 218
           Torticollis, 521                     open, 155                        Ultraviolet light, 34, 221
           Toxic granules, in neutrophils, 348  oral cavity, 523                 Unicameral, bone cyst, 839-40
           Toxic shock, 109, 110-11             primary, 153-55                  Union, wounds, 168-69
           Toxoplasmosis, 191                   pulmonary, 154-56                  primary, 168
           TP53 gene, 213                       secondary, 155-56                  secondary, 168-69
           Trace elements, 254                  sinus tracts in, 153             Urachal abnormalities, 698
           Tracheo-oesophageal fistula, 538     spread of, 151-52                Urachal cyst, 698
           Trachoma, 508                        transmission of, 151             Uraemia, 655-56
           Tram-track appearance, 671         Tuberculous meningitis, 876        Uraemic manifestations, 655-56
           Transaminases, 595, 898            Tubular necrosis, acute (ATN), 679-80  Urate nephrolithiasis, 692
           Transcellular fluid, 93            Tubules,                           Ureter, normal structure of, 698
           Transcobalamin, 253, 303-04          diseases of, 678-80              Ureterocele, 698
           Transcoelomic spread, 202-03, 750    structure of, 651-52             Urethra, normal structure of, 698
           Transferrin, 295                   Tubulointerstitial disease, 680-85  Urethral carcinoma, 702
           Transfusion, of blood, 339-40      Tumoral calcinosis, 779            Urethral caruncle, 702
             complications of, 339-40         Tumour host interrelationship, 228-32  Urethritis, 699-700
           Transient ischaemic attacks (TIA), 879  Tumour markers, 233-34, 709, 720  Uric acid stones, 692
           Transitional cell carcinoma,       Tumour necrosis factor (TNF), 25-26, 109,  Urinary bladder, 698-700
             nasopharynx, 518-19                   138-39, 146, 230, 381           normal structure of, 698
             urinary bladder, 700-02          Tumours (also see under Neoplasia), 192-235  tumours of, 700-702
           Translocations, 199, 259, 353, 355, 356f, 358  anaplasia in, 197      Urinary calculi, 690-92
             reciprocal, 259                    angiogenesis in, 199, 215        Urinary cytology, 273, 276
             Robertsonian, 259                  benign versus malignant, 194     Urinary tract infection (UTI), 681, 682, 698
           Transplant rejection, 65-66          characteristics of, 194-204      Urinary tract, lower, 698-702
           Transplantation, 65                  classification of, 193t          Urine analysis, 652
             cardiac, 460                       cytomorphology of, 197-99        Urobilinogen, 593
             bone marrow, 326, 365, 374         diagnosis of, 232-35             Urolithiasis, 690-92
           Transposition of great arteries, 425-26  differentiation in, 197      Uropathy, obstructive, 690-93
           Transthyretin, 83                    epidemiology of, 205-07          Urothelial tumours, 700-02
           Transudate versus exudate, 96t       etiology and pathogenesis of, 208-28  Urticaria, 97, 770
           Trauma to brain, 882-83              functional changes in, 198       Urticaria pigmentosa, 770
           Trephine, 286-87                     genetic abnormalities in, 199    Uveal melanoma, 512
           Treponema, 161                       grading of, 204                  Uveitis, 508
           Trichoepithelioma, 785               gross features of, 196
           Trichomoniasis, 270f                 growth rate of, 194-96
           Trigone, 698                         inflammatory reaction in, 199-200  V
           Triphenyl tetrazolium chloride (TTC), 432  invasion of, 200-04
           Triple response, 131f                metastasis in, 200-04            Vaccines, hepatitis, 614
           Trisomy, 258                         microscopic features of, 196-200  Vaccinia, 186, 773
           Tropical pulmonary eosinophilia, 456, 494  phenotype of, 196          Vagina, 723-24
           Troponins, cardiac, 417, 435         spread of, 200-04                  normal structure of, 723
     INDEX
           Trouisier’s sign, 557                staging of, 205                    tumours of, 723-24
           Trousseau’s syndrome, 232, 410, 503, 648  stem cells in, 196          Vaginal smear, 268-72, 275
           Truncus arteriosus, persistent, 425  stroma of, 199                   Vaginitis, 723
           Trypanosomiasis, 453, 538, 580       vascular invasion of, 201-02       monilial, 270, 723
           Tryptophan, 243                    Tunicae, arteries, 390             Valvular deformities, 426, 449-51
           Tubercle, 152-53,                  Turban tumour, 786                 Valvulitis, rheumatic, 440-41
             evolution of, 152-53, 155, 156   Turbulence, 116, 133               van den Bergh diazo reaction, 593
             hard and soft, 153               Turcot’s syndrome, 586             Vanillyl mandellic acid (VMA), 800
           Tubercle bacillus, 149             Turk cell, 349                     Varicella-zoster infection, 186, 773
           Tuberculin test, 152               Turner’s syndrome, 258             Varices, 539-40, 631-32
           Tuberculoma, brain, 877            Typhoid fever, 571-72              Varicocele, 706
           Tuberculosis, 149-57               Typhoid ulcers, 572f               Varicosities, 409
             brain, 877                       Tyrosinase, 40                     Variola, 186, 773
             caseous necrosis in, 45, 153, 155, 156                              Vasa recta, 650
             caseous pneumonia in, 156                                           Vasa vasora, 390
             causative organism in, 149       U                                  Vascular purpuras, 331
             cavitary, 155-56                                                    Vascular permeability, 130-33
             clinical features of, 156-57     Ubiquitin, 26                        alterations of, 131
             dystrophic calcification in, 52f  UICC staging,  205                  mechanisms of, 131-33
             fibrocaseous, 155-56             Ulcer,                             Vascular tumours, 411-16
             hypersensitivity and immunity in, 152  amoebic, 187-88              Vasculitis, 400-05
             incidence of, 151                  aphthous, 522-23                   allergic, 402-03
             intestinal, 569-71                 Curling’s, 113, 550                hypersensitvity, 402-03, 404
             kidney, 156, 684                   Cushing’s, 550                     leucocytoclastic, 403f
             liver, 162, 615-16                 peptic, 549-54                     lymphocytic, 403
             lymph node, 45, 154f               rodent, 784-85                   Vasoactive amines, 136-37
   943   944   945   946   947   948   949